Medindia
Advertisement

$68 million aid pours in from Gates Foundation to fight tropical diseases

by Medindia Content Team on September 15, 2006 at 4:44 PM
Font : A-A+

$68 million aid pours in from Gates Foundation to fight tropical diseases

Seattle: The initiatives to combat tropical diseases that ails many millions of people in parts of Africa, Asia and Latin America, was given a renewed thrust by The Bill & Melinda Gates Foundation, which announced four grants totaling to more than $68.2 million.

This fund will assist in controlling three diseases - hookworm, leishmaniasis and trypanosomiasis - which are spread by parasites and worms. These worms are lethal in that they could impair child growth and development for life.

Advertisement

Presently no vaccines are available to prevent these diseases and the drugs that are available for treatments are too costly and prone to side effects. "Many of the world's most debilitating illnesses are virtually unheard of in the rich world. But they're a fact of life for millions of people in poor countries," said Tachi Yamada, president of the global health program at the Gates Foundation.

The funds will do a world of good to bring reprieve to the ailing millions in the grips of debilitating illnesses.



Source: Medindia
SAV
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use